Skip to Main Content

Elizabeth Claus, PhD, MD

Professor of Biostatistics; Director of Medical Research, School of Public Health
DownloadHi-Res Photo

About

Titles

Professor of Biostatistics; Director of Medical Research, School of Public Health

Biography

Elizabeth B. Claus, MD, PhD is Professor and Director of Medical Research in the Yale University School of Public Health as well as Attending Neurosurgeon and Director of Stereotactic Radiosurgery within the Department of Neurosurgery at Brigham and Women’s Hospital in Boston. She is a member of the board of advisors for the Acoustic Neuroma Association (ANA) as well as the Central Brain Tumor Registry of the United States (CBTRUS). Dr. Claus' work is focused in cancer and genetic epidemiology with an emphasis on the development of risk models for breast and brain tumors. She is the overall PI of the Meningioma Consortium, the Meningioma Genome-Wide Association Study, and the Yale Acoustic Neuroma Study as well as a co-investigator of the GLIOGENE (Genes for Glioma) and International Glioma Case/Control (GICC) projects. In addition to her research activities, Dr. Claus is a Board-certified neurosurgeon who completed her residency in neurosurgery at Yale-New Haven Hospital and her fellowship in neurosurgical oncology at Brigham and Women’s Hospital. Her clinical focus is on the treatment of meningioma, glioma, acoustic neuroma and brain metastases.

Claus launched the International Low-Grade Glioma (LGG) Registry in 2016 to discover why some people develop LGG, a slow growing but malignant brain tumor primarily affecting young adults, while others do not. The goal of the registry is also to learn more about the effect of this diagnosis and the associated treatments on daily life including the ability to work, drive, sleep, exercise, or take care of oneself and/or a family member. Recently Dr. Claus and a team of fellow scientists received funds from the National Cancer Institute to investigate the molecular evolution of LGG. The project, OPTimIzing engageMent in discovery of molecular evolution of low grade glioma” or OPTIMUM, will enroll 500 participants diagnosed with LGG and who have had two or more surgeries for their glioma and genotype these tumors to establish a comprehensive genomic characterization of the glioma tumors across time.




Appointments

Other Departments & Organizations

Education & Training

Fellow
Brigham and Women's Hospital (2003)
Resident
Yale-New Haven Hospital (2002)
Resident
Yale- New Haven Hospital (1996)
MD
Yale University School of Medicine (1994)
PhD
Yale University (1988)

Research

Overview

  • The Yale Breast Study
  • The DCIS and BRCA1/2 Cohort Study
  • The Meningioma Consortium Project
  • The Meningioma Family Study
  • The Meningioma Genome-Wide Association Study
  • GLIOGENE (Genes for Glioma)
  • The International Glioma Case/Control Study (GICC)
  • The Yale Acoustic Neuroma Study (acousticneuroma@yale.edu)
  • The International Low Grade Glioma Project (glioma@yale.edu)

Medical Subject Headings (MeSH)

Astrocytoma; Breast Neoplasms; Central Nervous System Neoplasms; Epidemiology; Glioma; Meningioma; Neurosurgery; Oligodendroglioma; Statistics as Topic

Research at a Glance

Yale Co-Authors

Frequent collaborators of Elizabeth Claus's published research.

Publications

2023

2021

2020

2019

Academic Achievements & Community Involvement

  • activity

    National Institutes of Health

  • honor

    Population Science Research Prize

  • honor

    Top 100 Publications, Yale Centennial

  • activity

    Acoustic Neuroma Association

  • activity

    Glioma Research Consortium

Get In Touch

Contacts

Academic Office Number
Appointment Number
Office Fax Number
Clinic Fax Number

Administrative Support

Locations

  • 60 College Street

    Academic Office

    Ste 205

    New Haven, CT 06510